Medicine and Dentistry
Rheumatoid Arthritis
81%
Patient
81%
Therapeutic Procedure
55%
Arthritis
9%
Follow up
9%
Synovial Fluid
8%
Development
7%
Spontaneous Remission
7%
Treatment Response
6%
Knee Joint
6%
Drug
5%
Observational Study
5%
Cohort Study
5%
Cohort Analysis
5%
Immunology and Microbiology
Inflammatory Arthritis
100%
Tumor Necrosis Factor
28%
Methotrexate
21%
Pneumococcal Vaccine
20%
Synovial Fluid
12%
Cartilage
10%
Immunogenicity
9%
Serotype
9%
Rheumatic Disease
8%
Matrix Protein
6%
Disease-Modifying Antirheumatic Drug
5%
Granulocyte
5%
Tumor Necrosis Factor Alpha
5%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Necrosis Factor Inhibitor
17%
Cohort Study
12%
Tumor Necrosis
11%
Remission
11%
Tumor Necrosis Factor
10%
Biological Product
10%
Sulfasalazine
7%
Disease Modifying Antirheumatic Drug
6%
Clinical Trial
5%
Antibodies
5%
Pharmacotherapy
5%
Adalimumab
5%
